4.7 Article

3-Aminophthalic acid, a new cereblon ligand for targeted protein degradation by O'PROTAC

期刊

CHEMICAL COMMUNICATIONS
卷 58, 期 14, 页码 2383-2386

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1cc06525d

关键词

-

资金

  1. Mayo Clinic Foundation
  2. ARA grant
  3. National Institutes of Health [R01CA134514, R01CA130908, R01CA197178, R01CA249282]

向作者/读者索取更多资源

In this study, a new ligand of cereblon (CRBN) E3 ubiquitin ligase, 3-aminophthalic acid, was identified and a phthalic acid-based O'PROTAC was developed for degradation of the ERG transcription factor. This phthalic acid-based O'PROTAC exhibited comparable efficacy in degrading ERG to pomalidomide-based ERG O'PROTACs. Moreover, phthalic acid, being more chemically stable and economical than classical immunomodulatory drugs (IMiDs), represents a new alternative as a ligand for the development of PROTACs, especially O'PROTACs.
In this study, we identified 3-aminophthalic acid as a new ligand of cereblon (CRBN) E3 ubiquitin ligase and developed a phthalic acid-based O'PROTAC for degradation of the ERG transcription factor. This phthalic acid-based O'PROTAC presented an efficacy in degrading ERG comparable to those displayed by pomalidomide-based ERG O'PROTACs. Moreover, phthalic acid-being more chemically stable and economical than classical immunomodulatory drugs (IMiDs)-represents, as a ligand, a new alternative for the development of PROTACs, especially O'PROTACs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据